My watch list
my.bionity.com  
Login  

20 Current news from the ressort price development

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Drug costs vary by more than 600% in study of 10 high-income countries

13-Jun-2017

In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at data on ...

more

Cell Medica granted Orphan Drug designation for novel cellular therapy

18-Mar-2015

Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announced ...

more

BASF increases prices for Vitamin E and A feed grade

14-Nov-2013

BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored.

more

Significant overall survival benefit observed with radium 223 in patients with castration-resistant prostate cancer

19-Jul-2013

Algeta ASA announced that data from the pivotal phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) trial of its drug radium Ra 223 dichloride (radium 223) in castration-resistant prostate cancer (CRPC) patients with symptomatic bone metastases and no known visceral metastatic disease ...

more

BASF increases prices for vitamin B2

07-Sep-2012

BASF globally increases the price for vitamin B2-products for human and animal nutrition by 10% with immediate effect respectively according to existing contracts terms at the earliest possible date.

more

Evonik increases prices of cGMP-grade amino acids

26-Apr-2012

Effective immediately, Evonik Industries is increasing the prices for the products L-Ornithine-L-Aspartate, L-Proline, L-Lysine salts, L-Methionine, L-Arginine-L-Aspartate, Glycine and all other cGMP-grade amino acids. The increase amounts to 10 – 20 percents and applies globally to all new ...

more

BASF increases prices for pharmaceutical excipients and active ingredients

31-Aug-2011

Effective September 1, 2011, BASF will increase the sales prices globally for all pharmaceutical excipients and generic active pharmaceutical ingredients by 10%. This price increase affects the entire excipients portfolio including all binders, disintegrants, coatings, solubilizers, and solvents. ...

more

Medivir Announces Positive 48-week Interim Data from TMC435 Hepatitis C Phase 2b ASPIRE Study in Treatment-Experienced Genotype-1 Patients

24-May-2011

Medivir AB announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful either ...

more

Evonik increases prices of pharmaceutical amino acids

11-May-2011

Effective immediately, Evonik Industries is increasing the prices of its pharmaceutical amino acids. The increase, of between 10 and 15 percent depending on the amino acid and its quality, applies globally to all new orders and new supply agreements. The price increase is a result of the ...

more

BASF increases prices for pharmaceutical excipients and active ingredients

05-Apr-2011

Effective April 1, 2011, BASF will increase the sales prices globally for all pharmaceutical excipients and active pharmaceuticals ingredients by at least 10% depending ...

more

Page 1 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE